Literature DB >> 8431012

Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acid.

A L Barry1, P C Fuchs, M A Pfaller.   

Abstract

In in vitro studies we evaluated the susceptibilities of beta-lactamase-producing and -nonproducing, ampicillin-resistant strains of Haemophilus influenzae and compared them with those of ampicillin-susceptible strains. Ampicillin, amoxicillin-clavulanic acid, ceftibuten, cefaclor, cefuroxime, cefixime, and cefotaxime were evaluated by broth microdilution tests and disk diffusion tests. The disk diffusion tests accurately categorized beta-lactamase-producing strains and ampicillin-susceptible strains as being susceptible to the study drugs other than ampicillin. Ampicillin-resistant, beta-lactamase-nonproducing strains were relatively resistant to all seven study drugs, but the disk diffusion test did not always predict that resistance. The clinical relevance of the decreased susceptibility to various agents remains unclear, but to be conservative, all ampicillin-resistant, beta-lactamase-nonproducing strains might be assumed to be resistant to other beta-lactams. After excluding that small group of isolates, reliable susceptibility test results were obtained with lots of Haemophilus Test Medium that met quality assurance criteria.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8431012      PMCID: PMC187597          DOI: 10.1128/AAC.37.1.14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Cefuroxime treatment failure of nontypable Haemophilus influenzae meningitis associated with alteration of penicillin-binding proteins.

Authors:  P M Mendelman; D O Chaffin; L R Krilov; G Kalaitzoglou; D A Serfass; O Onay; E A Wiley; G D Overturf; L G Rubin
Journal:  J Infect Dis       Date:  1990-11       Impact factor: 5.226

2.  Interpretive criteria and quality control limits for ceftibuten disk susceptibility tests. Collaborative Antimicrobial Susceptibility Testing Group.

Authors:  A L Barry; R N Jones
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

Review 3.  Haemophilus influenzae: antibiotic susceptibility.

Authors:  C A Needham
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

4.  Problems with current recommendations for susceptibility testing of Haemophilus influenzae.

Authors:  P M Mendelman; E A Wiley; T L Stull; C Clausen; D O Chaffin; O Onay
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

5.  In vitro activities and targets of three cephem antibiotics against Haemophilus influenzae.

Authors:  P M Mendelman; L L Henritzy; D O Chaffin; K Lent; A L Smith; T L Stull; E A Wiley
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

6.  Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae.

Authors:  J H Jorgensen; J S Redding; L A Maher; A W Howell
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

7.  Ceftibuten (7432-S, SCH 39720): comparative antimicrobial activity against 4735 clinical isolates, beta-lactamase stability and broth microdilution quality control guidelines.

Authors:  R N Jones; A L Barry
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-12       Impact factor: 3.267

8.  Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae.

Authors:  P M Mendelman; D O Chaffin; T L Stull; C E Rubens; K D Mack; A L Smith
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

9.  National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae.

Authors:  G V Doern; J H Jorgensen; C Thornsberry; D A Preston; T Tubert; J S Redding; L A Maher
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

10.  Haemophilus influenzae ATCC 49766, an alternative quality control strain for monitoring broth microdilution susceptibility tests with selected beta-lactams.

Authors:  A L Barry; J H Jorgensen; D J Hardy; S D Allen; C N Baker
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

View more
  10 in total

Review 1.  Antimicrobial agents for community-acquired respiratory tract infections.

Authors:  A L Barry
Journal:  Infection       Date:  1995       Impact factor: 3.553

2.  Susceptibility of bacterial respiratory pathogens to amoxicillin and amoxicillin-clavulanic acid.

Authors:  A L Barry; P C Fuchs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-05       Impact factor: 3.267

3.  Antimicrobial resistance in Haemophilus influenzae isolated during population-based surveillance for meningitis in Salvador, Brazil.

Authors:  Joice Neves Reis; Josilene Borges Lima; Guilherme Souza Ribeiro; Soraia Machado Corderio; Kátia Salgado; Mitermayer Galvão Reis; Albert I Ko
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

Review 4.  beta-Lactamases in laboratory and clinical resistance.

Authors:  D M Livermore
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

5.  Disk diffusion versus broth microdilution susceptibility testing of Haemophilus species and Moraxella catarrhalis using seven oral antimicrobial agents: application of updated susceptibility guidelines of the National Committee for Clinical Laboratory Standards.

Authors:  P C Kibsey; R P Rennie; J E Rushton
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

6.  Evaluation of API NH, a new 2-hour system for identification of Neisseria and Haemophilus species and Moraxella catarrhalis in a routine clinical laboratory.

Authors:  G Barbé; M Babolat; J M Boeufgras; D Monget; J Freney
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

7.  Susceptibility of Haemophilus influenzae to piperacillin-tazobactam combinations: interpretive criteria and quality control limits for standardized tests.

Authors:  A L Barry; P C Fuchs; J H Jorgensen; F C Tenover; S D Allen; D J Hardy; J C McLaughlin
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

8.  In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993.

Authors:  A L Barry; M A Pfaller; P C Fuchs; R R Packer
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

9.  Molecular epidemiology of ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae.

Authors:  L Gazagne; C Delmas; E Bingen; H Dabernat
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

Review 10.  Ceftibuten. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.

Authors:  L R Wiseman; J A Balfour
Journal:  Drugs       Date:  1994-05       Impact factor: 9.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.